The results below are for 192 out of 193 participants who took at least 1 dose of
study treatment and reported if they had any medical problems.
Did any adverse reactions happen during this study?
Ticagrelor Placebo
(out of 100 (out of 92
participants) participants)
How many
participants had 6.0% (6) 2.2% (2)
adverse reactions?
How many
participants had
1.0% (1) 0.0% (0)
serious adverse
reactions?
How many
participants stopped
taking study 1.0% (1) 0.0% (0)
treatment due to
adverse reactions?
The study sponsor stopped this study early because the researchers did not think
ticagrelor was helping the participants.
What serious adverse reactions happened during this study?
There was 1 participant out of 100 who took ticagrelor who had a serious adverse
reaction during the study and who died owing to a serious adverse reaction. This
was 1.0% of participants. The serious adverse reaction was a sudden unexplained
death.
None of the other participants who took ticagrelor had serious adverse reactions
during the study or died owing to serious adverse reactions.
None of the participants who took the placebo had serious adverse reactions or
died owing to serious adverse reactions.
9 | Clinical Study Results